Johnson & Johnson Shares Fall after Posting Flat Q4 Results (JNJ)

By
A A A
Share |

Healthcare giant Johnson & Johnson ( JNJ ) on Tuesday said its fourth quarter profit was mostly flat from last year, matching analyst estimates, but revenue fell short of expectations.

The New Brunswick, NJ-based company reported fourth quarter net income of $2.86 billion, or $1.03 per share, compared with $2.85 billion, or $1.02 per share, in the year-ago period.

Revenue fell more than 5% from last year to $15.64 billion.

On average, Wall Street analysts expected a matching profit of $1.03 per share, albeit on higher revenue of $16.02 billion.

Johnson & Johnson shares fell $1.54, or -2.5%, in premarket trading Tuesday.

The Bottom Line
We have been recommending shares of Johnson & Johnson ( JNJ ) since Oct.8, 2009, when the stock was trading at $60.71. The company has a 3.47% dividend yield, based on last night's closing stock price of $62.22.

Johnson & Johnson ( JNJ ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: JNJ

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

80%

Most Active by Volume

48,099,947
  • $16.09 ▲ 0.50%
40,277,806
  • $102.50 ▲ 0.24%
40,236,499
  • $19.57 ▲ 2.35%
31,092,510
  • $49.75 ▲ 0.65%
30,795,218
  • $34.92 ▲ 0.78%
29,910,855
  • $3.63 ▲ 0.83%
24,019,154
  • $13.06 ▼ 0.38%
23,753,906
  • $74.82 ▲ 1.31%
As of 8/29/2014, 04:04 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com